Lonza awaits licence for Swiss plant making Moderna COVID-19 vaccine ingredients
By John MillerZURICH, Jan 14 (Reuters) - A new Swiss production line where contract drugmaker Lonza is making active ingredients for Moderna's COVID-19...
By John MillerZURICH, Jan 14 (Reuters) - A new Swiss production line where contract drugmaker Lonza is making active ingredients for Moderna's COVID-19...